Description: This session will cover everything you've wanted to know about GLMs but were too afraid to ask. How do these generalized models relate to the plain linear regression, and how can we be sure that the models we implement are appropriate for the task at hand?

Description: Explore the value and cost of prescription drugs, how they should be defined and measured and the effects various stakeholders in the pharmacy ecosystem can have on these factors in the latest webcast. You'll investigate the impact of coverage, formulary and rebate negotiations and related benefit design. Find out how actuaries can answer questions related to the prescription drug industry, in addition to improving the access, quality and affordability of prescription drugs in the United States. Join us for this webcast and come learn about value-based contract design, negotiations, implementation and administration for prescription drugs.

Description: Session 2F: Artificial Intelligence and Actuarial Modeling - Ask an Expert!

Description: This panel discussion will focus on how companies have been able to take advantage of the new US GAAP requirements, to develop and refine other performance indicators that provide additional insights into their business.

Description: Actuarial funding of OPEB plans is primarily a public sector phenomenon due to the different regulations and tax laws that impact private sector organizations in the US. OPEB funding started to gain momentum with the implementation of GASB Statement 45 in the mid to late 2000s.

Description: Zero-Knowledge Proofs (ZKPs) represent an innovative suite of cryptographic algorithms that empower the insurance community to validate the accuracy of sensitive information without revealing the actual information itself. Mutation with the use of non-traditional data entering the insurance processes of customer acquisition and in-force management is currently taking place. A shift toward using non-traditional data in insurance customer acquisition and in-force management processes is currently taking place. This evolution is captured in the Australian market through surveys and interviews. Come and join us to learn about these two new research studies that open up the possibilities for the insurance industry to be more efficient in delivering its value to the society.

Description: With IFRS 17 effective this year, come learn about the performance management capabilities provided by IFRS 17 with traditional analysis under IFRS4, and with LDTI under USGAAP. You will begin with an introduction to the IFRS 17 landscape post implementation, followed by a comparison of profit measurement and earning analysis key performance indicators (KPIs) pre- and post-IFRS 17, and ends with an exploration of the common philosophy of earning recognition between LDTI and IFRS 17 beyond the calculation differences.

Description: As the size of the life reinsurance market in Bermuda has grown to over half a trillion dollars at the end of 2021, more and more actuaries are getting involved with this 21 square mile North Atlantic island in one way or the other. Come explore a fundamental understanding of the Bermuda solvency framework and an overview of its upcoming changes.

Description: Keynote Speaker: J.D. Kleinke, Author and Medical Economist J.D. Kleinke has been instrumental in the creation of four health care information organizations; has served on the Boards of several health care companies; and spent many years advising both sides of the political aisle on non-partisan, practical approaches to health policy and legislation.

Description: How do Professionalism and the Actuarial Standards of Practice apply as the way we work and tools we use continue to change? Business is conducted via social media and messaging and Generative AI allows for additional scenarios, analysis and oversight. Join us for an interactive session to go deeper into these topics including case studies, polls and a panel discussion.